Mark Pruzanski
Direttore/Membro del Consiglio presso EQUILLIUM, INC.
Patrimonio netto: 35 699 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Mark Pruzanski
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
McGill University
222
| College/University | Other Consumer Services | 222 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
McMaster University
72
| College/University | Other Consumer Services | 72 |
| Public Company | Pharmaceuticals: Major | 57 | |
| Public Company | Biotechnology | 18 | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million.
7
| Subsidiary | Biotechnology | 7 |
Foundation for the Defense of Democracies
7
| Private Company | 7 | |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Johns Hopkins University School of Advanced International
2
| College/University | Other Consumer Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Pruzanski tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal President Public Communications Contact | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Sales & Marketing Corporate Officer/Principal | |
CropLife International
 CropLife International Advertising/Marketing ServicesCommercial Services CropLife International operates as a marketing agency for agricultural innovations in crop protection and plant biotechnology. The private company is based in Brussels, Belgium. | Advertising/Marketing Services | Director/Board Member Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| BIOCON LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Trialspark, Inc.
 Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| BIOMX INC. | Biotechnology | Director/Board Member Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Georgia | College/University | Graduate Degree Doctorate Degree | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| University of Glasgow | College/University | Undergraduate Degree Undergraduate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
BioMed Ventures
 BioMed Ventures Investment ManagersFinance BioMed Ventures (BioMed Ventures) is a venture capital firm subsidiary of BioMed Realty founded in 2010. The firm is headquartered in San Diego, California. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Birmingham | College/University | Doctorate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Regno Unito | 5 |
| Israele | 3 |
| Francia | 2 |
| Belgio | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Finance | 5 |
Posizioni
| Director/Board Member | 741 |
| Corporate Officer/Principal | 238 |
| Independent Dir/Board Member | 189 |
| Chairman | 167 |
| Chief Executive Officer | 130 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Steven Gillis | 58 |
| Daniel Bradbury | 45 |
| Jonathan Leff | 45 |
| Robert More | 42 |
| Jonathan Silverstein | 42 |
| John Maraganore | 38 |
| Jon Fyrwald | 35 |
| Ted Love | 31 |
| David Willetts | 29 |
| Steven Holtzman | 28 |
| David Pyott | 27 |
| James Sapirstein | 26 |
| James Collins | 23 |
| Barbara Duncan | 22 |
- Borsa valori
- Insiders
- Mark Pruzanski
- Connessioni Società
